FindTrial
Sign In

Benefit of dextrose injection in treatment of heel pain

Efficacy of dextrose prolotherapy in the treatment of plantar fasciitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040669
Enrollment
50
Registered
2022-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M796- Pain in limb, hand, foot, fingersand toes

Interventions

Intervention1: Dextrose prolotherapy: 1.5 ml of 20% dextrose and 0.5 ml of 0.5% lidocaine resulting in 15% dextrose solution Follow up at 0, 2 and 8 weeks Control Intervention1: Not applicable: Not a

Sponsors

VMMC Safdarjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of plantar fasciitis with duration of symptoms more than 3 months

Exclusion criteria

Exclusion criteria: 1. Recent history of trauma and calcaneal fracture 2. Prior injection treatment for heel pain within 6 months 3. Prior surgery for plantar fasciitis 4. Active infection at injection site 5. Uncontrolled diabetes mellitus 6. Bleeding disorders 7. Dementia and other psychiatric illness

Design outcomes

Primary

MeasureTime frame
1. Pain using Numeric Pain Rating Scale 2. Foot function using Foot Function Index 3. Plantar fascia thicknessTimepoint: At 0, 2 and 8 weeks—

Secondary

MeasureTime frame
Plantar fascia thickness on USGTimepoint: At 0, 4 and 8 week—

Countries

India

Contacts

Public ContactDr Malovika Biswas

Vardhman Mahavir Medical College and Safdarjung Hospital

rkwadhwa79@gmail.com01126164887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026